Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactamica 9: N. lactamica in pregnant women
NCT04784845Completed
- Sponsor
- University of Southampton
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label, single-arm trial of Neisseria lactamica Y92-1009 in meningococcal disease, sponsored by University of Southampton. Primary endpoint: Neonatal Neisseria lactamica colonisation. Started Oct 2021; status: completed.
02
Drugs
Neisseria lactamica Y92-1009
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT04784845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04784845.